Mephedrone

Novel Psychoactive Substances: Classification, Pharmacology and Toxicology

Volumn , Issue , 2013, Pages 211-231

  Wood, David M ^a   Dargan, Paul I ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

4 methylmethcathinone; Mephedrone; Novel psychoactive substances; Synthetic cathinones

Indexed keywords

EID: 84903807815     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-415816-0.00009-2     Document Type: Chapter

References (81)

1. Gibbons S 'Legal highs' - novel and emerging psychoactive drugs: a chemical overview for the toxicologist. Clin Toxicol (Phila) 2012, 50:15-24.
2. Gibbons S, Zloh M An analysis of the 'legal high' mephedrone. Bioorg Med Chem Lett 2010, 20:4135-4139.
3. EMCDDA Annual report 2012: the state of the drugs problem in Europe. Available: <> [accessed 18.02.13]. http://www.emcdda.europa.eu/attachements.cfm/att_190854_EN_TDAC12001ENC_.pdf.
4. EMCDDA Risk assessments: report on the risk assessment of mephedrone in the framework of the council decision on new psychoactive substances. Available: <> [accessed 18.02.13]. http://www.emcdda.europa.eu/attachements.cfm/att_116646_EN_TDAK11001ENC_WEB-OPTIMISED%20FILE.pdf.
5. Camilleri A, Johnston MR, Brennan M, Davis S, Caldicott DG Chemical analysis of four capsules containing the controlled substance analogues 4-methylmethcathinone, 2-fluoromethamphetamine, alpha-phthalimidopropiophenone and N-ethylcathinone. Forensic Sci Int 2010, 197:59-66.
6. Newcombe R. Mephedrone. The use of mephedrone (M-cat, Meow) in Middlesbrough. Manchester, UK: Lifeline Publications and Research; Available: <> [accessed 18.02.13]. http://www.ewsd.wiv-isp.be/Publications%20on%20new%20psychoactive%20substances/Mephedrone/M-cat%20report%20small.pdf.
7. Psychonaut WebMapping Research Group Mephedrone report 2009, Institute of Psychiatry, King's College London, London.
8. Schifano F, Albanese A, Fergus S, Psychonaut Web Mapping, ReDNet Research Groups, et al. Mephedrone (4-methylmethcathinone; 'meow meow'): chemical, pharmacological and clinical issues. Psychopharmacology (Berl) 2011, 214:593-602.
9. 4-Methylmethcathinone basics. Available: <> [accessed 18.02.13]. http://www.erowid.org/chemicals/4_methylmethcathinone/4_methylmethcathinone_basics.shtml.
10. Prosser JM, Nelson LS The toxicology of bath salts: a review of synthetic cathinones. J Med Toxicol 2012, 8:33-42.
11. Spiller HA, Ryan ML, Weston RG, Jansen J Clinical experience with and analytical confirmation of 'bath salts' and 'legal highs' (synthetic cathinones) in the United States. Clin Toxicol (Phila) 2011, 49:499-505.
12. 4-Methylmethcathinone reports. Available: <> [accessed 18.02.13]. http://www.erowid.org/experiences/subs/exp_4Methylmethcathinone.shtml.
13. Mephedrone and Beta-Ketones. Available: <> [accessed 18.02.13]. http://www.drugs-forum.com/forum/forumdisplay.php?f=377.
14. Wood DM, Davies S, Puchnarewicz M, Button J, Archer R, Ovaska H, et al. Recreational use of mephedrone (4-methylmethcathinone, 4-MMC) with associated sympathomimetic toxicity. J Med Toxicol 2010, 6:327-330.
15. Measham F, Moore K, Newcombe R, Welch Z Tweaking, bombing, dabbing and stockpiling: the emergence of mephedrone and the perversity of prohibition. Drugs Alcohol Today 2010, 10:14-21.
16. Dick D, Torrance C MixMag drugs survey. MixMag 2010, 225:44-53.
17. Winstock A, Mitcheson L, Ramsey J, Davies S, Puchanarewicz Marsden J Mephedrone: use, subjective effects and health risks. Addiction 2011, 106:1991-1996.
18. 4-Methylmethcathinone dose. Available: <> [accessed 18.02.13]. http://www.erowid.org/chemicals/4_methylmethcathinone/4_methylmethcathinone_dose.shtml.
19. James D, Adams RD, Spears R, National Poisons Information Service, et al. Clinical characteristics of mephedrone toxicity reported to the UK National Poisons Information Service. Emerg Med J 2011, 28:686-689.
20. Regan L, Mitchelson M, Macdonald C Mephedrone toxicity in a Scottish emergency department. EMJ 2011, 28:1055-1058.
21. Wood DM, Davies S, Greene SL, Button J, Holt DW, Ramsey J, et al. Case series of individuals with analytically confirmed acute mephedrone toxicity. Clin Toxicol (Phila) 2010, 48:924-927.
22. Wood DM, Greene SL, Dargan PI Clinical pattern of toxicity associated with the novel synthetic cathinone mephedrone. Emerg Med J 2011, 28:280-282.
23. Meyer MR, Wilhelm J, Peters FT, Maurer HH Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography-mass spectrometry. Anal Bioanal Chem 2010, 397:1225-1233.
24. 2. J Pharm Biomed Anal 2013, 72:177-185.
25. Pedersen AJ, Reitzel LA, Johansen SS, Linnet K In vitro metabolism studies on mephedrone and analysis of forensic cases. Drug Test Anal 2012 May 9, [Epub ahead of print].
26. Wright MJ, Angrish D, Aarde SM, Barlow DJ, Houseknecht KL, Dickerson TJ, et al. Effect of ambient temperature on the thermoregulatory and locomotor stimulant effects of 4-methylmethcathinone in Wistar and Sprague-Dawley rats. PLoS One 2012, 7:e44652.
27. 4-Methylmethcathinone effects. Available: <> [accessed 18.02.13]. http://www.erowid.org/chemicals/4_methylmethcathinone/4_methylmethcathinone_effects.shtml.
28. Martínez-Clemente J, Escubedo E, Pubill D, Camarasa J Interaction of mephedrone with dopamine and serotonin targets in rats. Eur Neuropsychopharmacol 2012, 22:231-236.
29. Baumann MH, Ayestas MA, Partilla JS, Sink JR, Shulgin AT, Daley PF, et al. The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue. Neuropsychopharmacology 2012, 37:1192-1203.
30. Kehr J, Ichinose F, Yoshitake S, Goiny M, Sievertsson T, Myberg F, et al. Mephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake rats. Br J Pharmacol 2011, 164:1949-1958.
31. Cameron K, Kolanos R, Verkariya R, De Felice L, Glennon RA Mephedrone and methylenedioxypyrovalerone (MDPV), major constituents of 'bath salts', produce opposite effects at the human dopamine transporter. Psychopharmacology (Berl) 2013, [Epub ahead of print].
32. Ramoz L, Lodi S, Bhatt P, Reitz AB, Tallarida C, Tallardia RJ, et al. Mephedrone ('bath salt') pharmacology: insights from invertebrates. Neuroscience 2012, 208:79-84.
33. Motbey CP, Hunt GE, Bowen MT, Artiss S, McGregor IS Mephedrone (4-methylmethcathinone, 'meow'): acute behavioural effects and distribution of Fos expression in adolescent rats. Addict Biol 2012, 17:409-422.
34. Shortall SE, Macerola AE, Swaby RT, Jayson R, Korsah C, Pilledge KE, et al. Behavioural and neurochemical comparison of chronic intermittent cathinone, mephedrone and MDMA administration to the rat. Eur Neuropsychopharmacol 2012 Oct 7, 10.1016/j.euroneuro.2012.09.005.
35. Motbey CP, Karanges E, Li KM, Wilkinson S, Winstock AR, Ramsay J, et al. Mephedrone in adolescent rats: residual memory impairment and acute but not lasting 5-HT depletion. PLoS One 2012, 7:e45473.
36. den Hollander B, Rozov S, Linden AM, Uusi-Oukari M, Ojanperä I, Korpi ER Long-term cognitive and neurochemical effects of 'bath salt' designer drugs methylone and mephedrone. Pharmacol Biochem Behav 2013, 103:501-509.
37. Shortall SE, Green AR, Swift KM, Fone KCF, King MV Lost in translation: preclinical studies on 3,4-methylenedioxymethamphetamine provide information on mechanisms of action, but do not allow accurate prediction of adverse events in humans. Br J Pharmacol 2012, 166:1523-1536.
38. Angoa-Pérez M, Kane MJ, Francescutti DM, Sykes KE, Shah MM, Mohammed AM, et al. Mephedrone, an abused psychoactive component of 'bath salts' and methamphetamine congener, does not cause neurotoxicity to dopamine nerve endings of the striatum. J Neurochem 2012, 120:1097-1107.
39. Meng H, Cao J, Kang J, Ying X, Ji J, Reynolds W, et al. Mephedrone, a new designer drug of abuse, produces acute hemodynamic effects in the rat. Toxicol Lett 2012, 208:62-68.
40. Varner KJ, Daigle K, Weed PF, Lewis PB, Mahne SE, Sankaranarayanan A, et al. Comparison of the behavioral and cardiovascular effects of mephedrone with other drugs of abuse in rats. Psychopharmacology (Berl) 2013, 225:675-685.
41. Europol-EMCDDA Joint report on a new psychoactive substance: 4-methylmethcathinone (mephedrone). Available: <> [accessed 18.02.13]. http://www.emcdda.europa.eu/attachements.cfm/att_132203_EN_2010_Mephedrone_Joint%20report.pdf.
42. Dargan PI, Sedefov R, Gallegos A, Wood DM The pharmacology and toxicology of the synthetic cathinone mephedrone (4-methylmethcathinone). Drug Test Anal 2011, 3:454-463.
43. United Nations Office on Drugs and Crime (UNODC) World Drug report 2012 <> [accessed 18.02.13]. http://www.unodc.org/documents/data-and-analysis/WDR2012/WDR_2012_web_small.pdf.
44. Drug Misuse Declared: Findings from the 2010/11 British Crime Survey England and Wales. Available: <> [accessed 18.02.13]. http://www.homeoffice.gov.uk/publications/science-research-statistics/research-statistics/crime-research/hosb1211/hosb1211?view=Binary.
45. Drug Misuse Declared: Findings from the 2011/12 Crime Survey for England and Wales. 2nd ed. July 2012. <> [accessed 18.02.13]. http://www.homeoffice.gov.uk/publications/science-research-statistics/research-statistics/crime-research/drugs-misuse-dec-1112/drugs-misuse-dec-1112-pdf?view=Binary.
46. Dargan PI, Albert S, Wood DM Mephedrone use and associated adverse effects in school and college/university students before the UK legislation change. QJM 2010, 103:875-879.
47. Meehan C. Doctoral study on adolescent drug taking in Northern Ireland. University of Ulster.
48. Winstock AR, Mitcheson LR, Deluca P, Davey Z, Corazza O, Schifano F Mephedrone, new kid for the chop?. Addiction 2011, 106:154-161.
49. Winstock A The 2011 MixMag drugs survey. MixMag 2011, 238:49-59.
50. Winstock A MixMag global drugs survey. MixMag 2012, 251:68-73.
51. Measham F, Moore K, Østergaard J Mephedrone, 'Bubble' and unidentified white powders: the contested identities of synthetic 'legal highs'. Drugs Alcohol Today 2011, 11:137-147.
52. Measham F, Wood DM, Dargan PI, Moore K The Rise in Legal Highs: prevalence and patterns in the use of illegal drugs and first and second generation 'legal highs' in south London gay dance clubs. J Subs Use 2011, 16:263-272.
53. Wood DM, Measham F, Dargan PI 'Our favourite drug': prevalence of use and preference for mephedrone in the London night time economy one year after control. J Subs Use 2012, 68:853-856.
54. Lea T, Reynolds R, De Wit J Mephedrone use among same-sex attracted young people in Sydney, Australia. Drug Alcohol Rev 2011, 30:438-440.
55. Bruno R, Matthews AJ, Dunn M, Alali R, McIlwraith F, Hickey S, et al. Emerging psychoactive substance use among regular ecstasy users in Australia. Drug Alcohol Depend 2012, 124:19-25.
56. Wood DM, Dargan PI Understanding how data triangulation identifies acute toxicity of novel psychoactive drugs. J Med Toxicol 2012, 8:300-303.
57. Adebamiro A, Perazella MA Recurrent acute kidney injury following bath salts intoxication. Am J Kidney Dis 2012, 59:273-275.
58. Centers for Disease Control, Prevention (CDC) Emergency department visits after use of a drug sold as 'bath salts'- Michigan, November 13, 2010- March 31, 2011. MMWR Morb Mortal Wkly Rep 2011, 60:624-627.
59. Kasick DP, McKnight CA, Klisovic E 'Bath salt' ingestion leading to severe intoxication delirium: two cases and a brief review of the emergence of mephedrone use. Am J Drug Alcohol Abuse 2012, 38:176-180.
60. Carhart-Harris RL, King LA, Nutt DJ A web-based survey on mephedrone. Drug Alcohol Depend 2011, 118:19-22.
61. Hägerkvist R, Hultén P, Personne M Increasing abuse of new cathinone derivatives in Sweden - a poisons centre study for the years 2008-2009. Clin Toxicol (Phila) 2010, 48:291-292.
62. Winstock A, Mitcheson L, Marsden J Mephedrone: still available and twice the price. Lancet 2010, 376:1537.
63. Wood DM, Greene SL, Dargan PI Emergency department presentations in determining the effectiveness of drug control in the United Kingdom: mephedrone (4-methylmethcathinone) control appears to be effective using this model. Emerg Med J 2013, 30:70-71.
64. Lusthof KJ, Oosting R, Maes A, Verschraagen M, Dijkhuizen A, Sprong AG A case of extreme agitation and death after the use of mephedrone in The Netherlands. Forensic Sci Int 2011, 206:e93-e95.
65. Wong ML, Holt RI The potential dangers of mephedrone in people with diabetes: a case report. Drug Test Anal 2011, 3:464-465.
66. Nicholson PJ, Quinn MJ, Dodd JD Headshop heartache: acute mephedrone 'meow' myocarditis. Heart 2010, 96:2051-2052.
67. Sammler EM, Foley PL, Lauder GD, Wilson SJ, Goudie AR, O'Riordan JI A harmless high?. Lancet 2010, 376:742.
68. Forsyth AJ Virtually a drug scare: mephedrone and the impact of the internet on drug news transmission. Int J Drug Policy 2012, 23:198-209.
69. Gustavsson D, Escher C Mephedrone - Internet drug which seems to have come and stay. Fatal cases in Sweden have drawn attention to previously unknown substance. Lakartidningen 2009, 106:2769-2771.
70. Dickson AJ, Vorce SP, Levine B, Past MR Multiple-drug toxicity caused by coadministration of 4-methylmethcathinon (mephedrone) and heroin. J Anal Toxicol 2010, 34:162-168.
71. Schifano F, Corkery J, Ghodse AH Suspected and confirmed fatalities associated with mephedrone (4-methylmethcathinone, 'meow meow') in the United Kingdom. J Clin Psychopharmacol 2012, 32:710-714.
72. Maskell PD, De Paoli G, Seneviratne C, Pounder DJ Mephedrone (4-methylmethcathinone)-related deaths. J Anal Toxicol 2011, 35:188-191.
73. Cosbey SH, Peters KL, Quinn A, Bentley A Mephedrone (methylmethcathinone) in toxicology casework: a Northern Ireland perspective. J Anal Toxicol 2013, 37:74-82.
74. Adamowicz P, Tokarczyk B, Stanaszek R, Slopianka M Fatal mephedrone intoxication - a case report. J Anal Toxicol 2013, 37:37-42.
75. Aromatario M, Bottoni E, Santoni M, Ciallella C New 'lethal highs': a case of a deadly cocktail of GHB and Mephedrone. Forensic Sci Int 2012, 223:e38-e41.
76. Freeman TP, Morgan CJ, Vaughn-Jones J, Hussain N, Karimi K, Curran HV Cognitive and subjective effects of mephedrone and factors influencing use of a 'new legal high'. Addiction 2012, 107:792-800.
77. Hadlock GC, Webb KM, McFadden LM, et al. 4-Methylmethcathinone (mephedrone): neuropharmacological effects of a designer stimulant of abuse. J Pharmacol Exp Ther 2011, 339:530-536.
78. Aarde SM, Angrish D, Barlow DJ, et al. Mephedrone (4-methylmethcathinone) supports intravenous self-administration in Sprague-Dawley and Wistar rats. Addict Biol 2013 Jan 30, 10.1111/adb.12038.
79. Pas M. Mephedrone in Slovenia. DrogArt report. May 2010. In: EMCDDA - Appendix 2 to Annex 1 (Technical report on mephedrone): Mephedrone. Additional studies, overview of prevalence, use patterns, effects. Available: <> [accessed 18.02.13]. http://www.ofdt.fr/BDD/publications/docs/rarOEDTmephA1A2.pdf.
80. Deluca P, Davey Z, Corazza O, et al. Identifying emerging trends in recreational drug use; outcomes from the Psychonaut Web Mapping Project. Prog Neuropsychopharmacol Biol Psychiatry 2012, 39:221-226.
81. Bajaj N, Mullen D, Wylie S Dependence and psychosis with 4-methylmethcathinone (mephedrone) use. BMJ Case Rep 2010, 2010 Nov 3. doi: pii: bcr0220102780.